Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions

BackgroundDendritic cells (DCs) are usually immunogenic, but they are also capable of inducing tolerance under anti-inflammatory conditions. Immunotherapy based on autologous DCs loaded with an allogeneic melanoma cell lysate (TRIMEL/DCs) induces immunological responses and increases melanoma patient survival. Glucocorticoids can suppress DC maturation and function, leading to a DC-mediated inhibition of T cell responses.MethodsThe effect of dexamethasone, a glucocorticoid extensively used in cancer therapies, on TRIMEL/DCs phenotype and immunogenicity was examined.ResultsDexamethasone induced a semi-mature phenotype on TRIMEL/DC with low maturation surface marker expressions, decreased pro-inflammatory cytokine induction (IL-1β and IL-12) and increased release of regulatory cytokines (IL-10 and TGF-β). Dexamethasone-treated TRIMEL/DCs inhibited allogeneic CD4⁺ T cell proliferation and cytokine release (IFNγ, TNF-α and IL-17). Co-culturing melanoma-specific memory tumor-infiltrating lymphocytes with dexamethasone-treated TRIMEL/DC inhibited proliferation and effector T cell activities, including cytokine secretion and anti-melanoma cytotoxicity.ConclusionsThese findings suggest that dexamethasone repressed melanoma cell lysate-mediated DC maturation, generating a potent tolerogenic-like DC phenotype that inhibited melanoma-specific effector T cell activities. These results suggest that dexamethasone-induced immunosuppression may interfere with the clinical efficacy of DC-based melanoma vaccines, and must be taken into account for optimal design of cellular therapy against cancer.     

Boron Removal by Sorption on Modified Chitosan Hydrogel Beads

An excess concentration of boron in irrigation and drinking water can negatively affect the yield of plants and the human nervous system, respectively. To meet the recommended levels, hybrid biosorbent hydrogel beads based on chitosan and manganese (II-IV) were employed for the removal of boron from aqueous media. The results showed that the biosorbent effectively removed boric acid from the aqueous medium at neutral pH over a sorption time of 2 h and the liquid/hydrogel ratio of 20 mL/g, achieving a maximum sorption capacity near 190 mg/g. The modeling of the sorption equilibrium data indicated that the Freundlich isotherm equation gave the best fit out of the isotherm models examined. A pseudo-second-order model was found to best describe the sorption kinetics. The favorable attachment of manganese to the chitosan structure enabled the sorption of boron and was confirmed by FTIR, RS, XRD, SEM and ICP-OES methods. Boron desorption from the spent biosorbent was successfully achieved in three cycles using a NaOH solution. In general, the results of this research indicate that this method is one of the possibilities for improving water quality and may contribute to reducing pollution of the aquatic environment.     

Calcium-independent release of [H]spermine from chick retina

Spermine has been shown to influence NMDA receptor function through an interaction at the coagonist site for glycine in the central nervous system (CNS) and the retina. In order to support a role for spermine as neurotransmitter or neuromodulator in the chick retina, specific stimulated-release of spermine should be demonstrated. Isolated chick retinas, preloaded with [³H]spermine, were stimulated with 1 mM NMDA and other glutamate agonists at ionotropic receptors, in a continuous superfusion system. [³H]spermine was released from the retina by depolarization with 50 mM KCl, in a Ca²⁺-independent manner. Inhibition of Na⁺/K⁺-ATPase by ouabain or digitoxigenin also induced spermine release following 36 min in the presence of the drugs; such effect seems unrelated to changes in Na⁺ electrochemical gradients, since nigericin and veratrine did not induce release in Na⁺ containing medium. The lack of effect of glutamate, NMDA and kainate at 1 mM concentration, suggests that release of spermine in the retina is mediated by the reversal of uptake and not necessarily linked to EAA-receptor activation.     

Efficacy of topical vitamin C in melasma and photoaging: A systematic review

Background

Vitamin C is a micronutrient present in high concentrations in normal skin and a highly prescribed cosmeceutical, well known for protecting against ultraviolet-induced pigmentation and regulating collagen production. However, there is a lack of studies evaluating the efficacy of topical vitamin C in photoaging and melasma, with this systematic review being the first to assess the existing evidence.

Aim

This systematic review aims to assess whether topical vitamin C could be effective in reversing photoaging signs and treating melasma.

Methods

Prospective, randomized controlled trials assessing protocols with topically applied vitamin C in patients with melasma or photodamage were searched in Medline, CENTRAL, and Scopus databases until the 12th of May 2022. Risk of bias was conducted in accordance with Cochrane Collaboration's tool for assessing the risk of bias in randomized trials, using RevMan 5.0.

Results

Seven publications were included, with 139 volunteers in total. Studies that evaluated the topography of skin indicated that the treated skin appeared smoother and less wrinkled, which was supported by biopsies data. On objective assessments of pigmentation, there was a significant lightening of the skin treated. Hydration improved equally in the vitamin C and placebo-treated sites.

Conclusions

This study revealed that vitamin C is effective in treating uneven, wrinkled skin and has depigmenting properties, but long-term use may be needed to achieve noticeable changes. Q-switched Nd:YAG laser-associated protocols appear beneficial in enhancing vitamin C effects. Topical vitamin C may be a suitable alternative for melasma and photoaging, but more studies are needed to confirm these results and assess the ideal vitamin C concentration.     

An efficient,one‐pot acylation of cellulose under homogeneous reaction conditions

Cellulose samples from cotton linters, sisal, and sugar cane bagasse have been successively acylated (acetate, propionate, butyrate, and acetate/butyrate) under homogeneous reaction conditions, in LiCl/N,N‐dimethylacetamide (DMAC), by the following procedure: (i) cellulose and LiCl are heated under reduced pressure, at 110°C; (ii) cellulose is dissolved in LiCl/DMAC by heating at 155°C, followed by cooling to 40°C; (iii) the solubilized polymer is acylated at 60°C for 18 h. Attractive features of this one‐pot procedure include: easy control and high reproducibility of the degree of substitution; elimination of base catalyst; negligible degradation of the natural polymer; and recovery/recycling of high purity DMAC and acid anhydride. Reaction conditions employed for the present celluloses are different from those previously used for Avicel PH 101 microcrystalline cellulose because their fibrous nature, higher indices of crystallinity and higher molecular weights retard their dissolution and decrease their rates of acylation by acid anhydrides.     

Cytotoxic and antitumour activity from Bursera fagaroides ethanol extract in mice with L5178Y lymphoma

Chloroform extracts of Bursera fagaroides (Burseracea) have previously shown antitumour activity against the Walker carcinoma 256 tumour system (WA16). In the present work we have determined the cytotoxic and antitumour activity of the ethanol extract (70%) of the bark of B. fagaroides using the L5178Y lymphoma. The cytotoxic activity is expressed as the ED₅₀ of the L5178Y lymphoma cells in culture, (20 µg/mL) whilst the antitumour activity was shown via a tumour growing inhibition test, measuring survival of BALB/c mice (2 × 10⁴ cells L5178Y i.p.). 24 h after inoculation mice were treated with 50 or 100 mg/kg of extract daily, over 15 days in independent groups of 10, using two administration routes. We observed the tumour evolution with and without treatment. Oral administration resulted in 8% of mice being tumour free after 60 day whilst intraperitoneal administration showed 26% survived at a dose of 100 mg/kg/day for 15 days. A significant increase in the survival of the treated animals (at 50 mg/kg/day over 15 days) was found compared with those treated with placebo or without treatment. Copyright © 1998 John Wiley & Sons, Ltd.